Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patients
Canada’s health care system is complex and involves the participation of multiple stakeholders, who all have distinct roles in the planning and delivery of healthcare services. Health Canada’s decision-making role in approving a drug for marketing is distinct from the roles of those who make decisions about price-setting and public drug plan reimbursements.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
Canada’s regulatory approach to drugs for rare diseases: our role in bringing drugs to patientsHTMLEnglish publication HTML